Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: A retrospective study

American Journal Geriatric Pharmacotherapy

Volumn 7, Issue 4, 2009, Pages 210-219

  Nishtala, Prasad S ^a   McLachlan, Andrew J ^a,b   Bell, J Simon ^a,c   Chen, Timothy F ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Microbiology and Infectious Diseases   (Australia)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

antidepressant agents; older people; pharmaceutical services; pharmacists; serotonin reuptake inhibitors; tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CITALOPRAM; CLOMIPRAMINE; DOSULEPIN; DOXEPIN; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGED; ARTICLE; AUSTRALIA; CLINICAL FEATURE; COGNITIVE DEFECT; DEMENTIA; DEMOGRAPHY; DEPRESSION; DRUG UTILIZATION; ELDERLY CARE; FEMALE; HOME FOR THE AGED; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; AUSTRALIA; DRUG PRESCRIPTIONS; FEMALE; HOMES FOR THE AGED; HUMANS; LOGISTIC MODELS; MALE; ODDS RATIO; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 70349132319     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2009.07.001     Document Type: Article

References (74)

1. Jones R.N., Marcantonio E.R., and Rabinowitz T. Prevalence and correlates of recognized depression in US nursing homes. J Am Geriatr Soc. 51 (2003) 1404-1409
2. Brown M.N., Lapane K.L., and Luisi A.F. The management of depression in older nursing home residents. J Am Geriatr Soc. 50 (2002) 69-76
3. Parmelee P.A., Katz I.R., and Lawton M.P. Incidence of depression in long-term care settings. J Gerontol 47 (1992) M189-M196
4. Anstey K.J., von Sanden C., Sargent-Cox K., and Luszcz M.A. Prevalence and risk factors for depression in a longitudinal, population-based study including individuals in the community and residential care. Am J Geriatr Psychiatry 15 (2007) 497-505
5. Tsai Y.F., Chung J.W., Wong T.K., and Huang C.M. Comparison of the prevalence and risk factors for depressive symptoms among elderly nursing home residents in Taiwan and Hong Kong. Int J Geriatr Psychiatry 20 (2005) 315-321
6. Lavretsky H., Kitchen C., Mintz J., et al. Medical burden, cerebrovascular disease, and cognitive impairment in geriatric depression: Modeling the relationships with the CART analysis. CNS Spectr. 7 (2002) 716-722
7. Maier W., Lichtermann D., Minges J., et al. Unipolar depression in the aged: Determinants of familial aggregation. J Affect Disord. 23 (1991) 53-61
8. Krishnan K.R., Delong M., Kraemer H., et al. Comorbidity of depression with other medical diseases in the elderly. Biol Psychiatry 52 (2002) 559-588
9. Lavretsky H., Mistry R., Bastani R., et al., the UPBEAT Collaborative Group. Symptoms of depression and anxiety predict mortality in elderly veterans enrolled in the UPBEAT program. Int J Geriatr Psychiatry 18 (2003) 183-184
10. Heston L.L., Garrard J., Makris L., et al. Inadequate treatment of depressed nursing home elderly. J Am Geriatr Soc. 40 (1992) 1117-1122
11. George K., Davison T.E., McCabe M., et al. Treatment of depression in low-level residential care facilities for the elderly. Int Psychogeriatr 19 (2007) 1153-1160
12. Snowdon J., and Fleming R. Recognising depression in residential facilities: An Australian challenge. Int J Geriatr Psychiatry 23 (2008) 295-300
13. Rovner B.W., German P.S., Brant L.J., et al. Depression and mortality in nursing homes [published correction appears in JAMA. 1991;265:2672]. JAMA 265 (1991) 993-996
14. Gallo J.J., Ryan S.D., and Ford D.E. Attitudes, knowledge, and behavior of family physicians regarding depression in late life. Arch Fam Med. 8 (1999) 249-256
15. Wilson K.C., Mottram P.G., and Vassilas C.A. Psychotherapeutic treatments for older depressed people. Cochrane Database Syst Rev. 1 (2008) CD004853
16. Lam R.W., Wan D.D., Cohen N.L., and Kennedy S.H. Combining antidepressants for treatment-resistant depression: A review. J Clin Psychiatry 63 (2002) 685-693
17. Ray W.A., Meredith S., Thapa P.B., et al. Cyclic antidepres-sants and the risk of sudden cardiac death. Clin Pharmacol Ther. 75 (2004) 234-241
18. Mottram P., Wilson K., and Strobl J. Antidepressants for depressed elderly. Cochrane Database Syst Rev. 1 (2006) CD003491
19. Streim J.E., Oslin D.W., Katz I.R., et al. Drug treatment of depression in frail elderly nursing home residents. Am J Geriatr Psychiatry 8 (2000) 150-159
20. Glassman A.H. Cardiovascular effects of antidepressant drugs: Updated. J Clin Psychiatry 59 Suppl 15 (1998) 13-18
21. Draper B., and Berman K. Tolerability of selective serotonin reuptake inhibitors: Issues relevant to the elderly. Drugs Aging 25 (2008) 501-519
22. Lebowitz B.D., Pearson J.L., Schneider L.S., et al. Diagnosis and treatment of depression in late life. Consensus statement update. JAMA. 278 (1997) 1186-1190
23. Reynolds III C.F., Dew M.A., Pollock B.G., et al. Maintenance treatment of major depression in old age. N Engl J Med. 354 (2006) 1130-1138
24. Hartikainen S., Lönnroos E., and Louhivuori K. Medication as a risk factor for falls: Critical systematic review. J Gerontol A Biol Sci Med Sci. 62 (2007) 1172-1181
25. Kirby D., and Ames D. Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients. Int J Geriatr Psychiatry 16 (2001) 484-493
26. Snowdon J., Day S., and Baker W. Current use of psychotropic medication in nursing homes. Int Psychogeriatr 18 (2006) 241-250
27. Kim H., and Whall A.L. Factors associated with psychotropic drug usage among nursing home residents with dementia. Nurs Res. 55 (2006) 252-258
28. Sørensen L., Foldspang A., Gulmann N.C., and Munk-Jørgensen P. Determinants for the use of psychotropics among nursing home residents. Int J Geriatr Psychiatry 16 (2001) 147-154
29. Lakey S.L., Gray S.L., Sales A.E., et al. Psychotropic use in community residential care facilities: A prospective cohort study. Am J Geriatr Pharmacother 4 (2006) 227-235
30. Barca M.L., Selbaek G., Laks J., and Engedal K. Factors associated with depression in Norwegian nursing homes. Int J Geriatr Psychiatry 24 (2009) 417-425
31. Arthur A., Matthews R., Jagger C., and Lindesay J. Factors associated with antidepressant treatment in residential care: Changes between 1990 and 1997. Int J Geriatr Psychiatry 17 (2002) 54-60
32. Snowden M., Sato K., and Roy-Byrne P. Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: A review of the literature. J Am Geriatr Soc. 51 (2003) 1305-1317
33. Medicare Australia. Medicare Australia Statistics. https://www.medicareaustralia.gov.au Accessed September 8, 2008
34. Guidelines and Standards for the Collaborative and Pharmacist Residential Medication Management Review (RMMR) Program and Quality Use of Medicines (QUM) Services. Pharmaceutical Society of Australia. http://www.psa.org.au/site.php?id=1122 Accessed December 8, 2008
35. eMIMS [computer program]. Version 5.01.0095 (2008), CMP-MedicaAustralia, St. Leonards, Australia
36. In: DiPiro J.T., Talbert R.L., Yee G.C., et al. (Eds). Pharmacotherapy: A Pathophysiologic Approach (2008), McGraw-Hill Medical, New York, NY 1240
37. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision (2004), WHO, Geneva, Switzerland
38. Cairney J., Corna L.M., Veldhuizen S., et al. Comorbid depression and anxiety in later life: Patterns of association, subjective well-being, and impairment. Am J Geriatr Psychiatry 16 (2008) 201-208
39. Smalbrugge M., Jongenelis L., Pot A.M., et al. Comorbidi-ty of depression and anxiety in nursing home patients. Int J Geriatr Psychiatry 20 (2005) 218-226
40. Di Michele V., and Bolino F. Post-stroke depression. Br J Psychiatry 176 (2000) 94-95
41. Teper E., and O'Brien J.T. Vascular factors and depression. Int J Geriatr Psychiatry 23 (2008) 993-1000
42. Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med. 23 (2002) 51-61
43. Sullivan K.L., Ward C.L., Hauser R.A., and Zesiewicz T.A. Prevalence and treatment of non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord. 13 (2007) 545
44. Casten R.J., Parmelee P.A., Kleban M.H., et al. The relationships among anxiety, depression, and pain in a geriatric institutionalized sample. Pain. 61 (1995) 271-276
45. Parmelee P.A., Katz I.R., and Lawton M.P. The relation of pain to depression among institutionalized aged. J Gerontol 46 (1991) P15-P21
46. Hosmer D.W., and Lemeshow S. Applied Logistic Regression. 2nd ed. (2000), Wiley, New York, NY
47. Watson L.C., Lehmann S., Mayer L., et al. Depression in assisted living is common and related to physical burden. Am J Geriatr Psychiatry 14 (2006) 876-883
48. Tucker M., and Hosford I. Use of psychotropic medicines in residential care facilities for older people in Hawke's Bay, New Zealand. N Z Med J. 121 (2008) 18-25
49. Mant A., Rendle V.A., Hall W.D., et al. Making new choices about antidepressants in Australia: The long view 19752002. Med J Aust. 181 Suppl (2004) S21-S24
50. Sonnenberg C.M., Deeg D.J., Comijs H.C., et al. Trends in antidepressant use in the older population: Results from the LASA-study over a period of 10 years. J Affect Disord. 111 (2008) 299-305
51. Psychotropic Expert Group. Therapeutic Guidelines: Psychotropic (2008), Therapeutic Guidelines Ltd, Melbourne, Australia 106-107 Version 6
52. Alexopoulos G.S., Katz I.R., Reynolds III C.F., et al. Pharmacotherapy of depression in older patients: A summary of the expert consensus guidelines. J Psychiatr Pract. 7 (2001) 361-376
53. Malhi G.S., Ng F., and Berk M. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression. Aust N Z J Psychiatry 42 (2008) 346-349
54. Rojo J.E., Ros S., Agüera L., et al. Combined antidepres-sants: Clinical experience. Acta Psychiatr Scand Suppl 25-31 (2005) 36
55. Benazzi F. Serotonin syndrome with mirtazapine-fluoxetine combination. Int J Geriatr Psychiatry 13 (1998) 495-496
56. Bhatara V.S., Magnus R.D., Paul K.L., and Preskorn S.H. Serotonin syndrome induced by venlafaxine and fluoxetine: A case study in polypharmacy and potential pharmacody-namic and pharmacokinetic mechanisms. Ann Pharmacother 32 (1998) 432-436
57. Preskorn S.H., and Baker B. Fatality associated with combined fluoxetine-amitriptyline therapy. JAMA. 277 (1997) 1682
58. McSweeney K., and O'Connor D.W. Depression among newly admitted Australian nursing home residents. Int Psychogeriatr 20 (2008) 724-737
59. Kanowski S. Age-dependent epidemiology of depression. Gerontology. 40 Suppl 1 (1994) 1-4
60. Blazer D. The epidemiology of depression in late life. J Geriatr Psychiatry 22 (1989) 35-52
61. Ptok U., Papassotiropoulos A., Maier W., and Heun R. Advanced parental age: A risk factor for Alzheimer's disease or depression in the elderly?. Int Psychogeriatr 12 (2000) 445-451
62. Steffens D.C., Skoog I., Norton M.C., et al. Prevalence of depression and its treatment in an elderly population: The Cache County study. Arch Gen Psychiatry 57 (2000) 601-607
63. Smalbrugge M., Jongenelis L.K., Pot A.M., et al. Pain among nursing home patients in the Netherlands: Prevalence, course, clinical correlates, recognition and analgesic treatment-an observational cohort study. BMC Geriatr. 7 (2007) 3
64. Hartikainen S., Mäntyselkä P., Louhivuori-Laako K., et al. Concomitant use of analgesics and psychotropics in home-dwelling elderly people-Kuopio 75+ study. Br J Clin Pharmacol 60 (2005) 306-310
65. Richeimer S.H., Bajwa Z.H., Kahraman S.S., et al. Utilization patterns of tricyclic antidepressants in a multidisci-plinary pain clinic: A survey. Clin J Pain. 13 (1997) 324-329
66. Gupta M.A., and Guptat A.K. The use of antidepressant drugs in dermatology. J Eur Acad Dermatol Venereol 15 (2001) 512-518
67. Hilmer S.N., McLachlan A.J., and Le Couteur D.G. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 21 (2007) 217-230
68. Stimmel G.L., Dopheide J.A., and Stahl S.M. Mirtazapine: An antidepressant with noradrenergic and specific serotoner-gic effects. Pharmacotherapy 17 (1997) 10-21
69. Johnell K., and Fastbom J. The use of benzodiazepines and related drugs amongst older people in Sweden: Associated factors and concomitant use of other psychotropics. Int J Geriatr Psychiatry. http://www3.interscience.wiley.com/journal/121617936/abstract Accessed February 10, 2009
70. Von Ruden A.E., Adson D.E., and Kotlyar M. Effect of selective serotonin reuptake inhibitors on cardiovascular morbidity and mortality. J Cardiovasc Pharmacol Ther. 13 (2008) 32-40
71. O'Connor C.M., Jiang W., Kuchibhatla M., et al. Anti-depressant use, depression, and survival in patients with heart failure. Arch Intern Med. 168 (2008) 2232-2237
72. Greene T., and Camicioli R. Depressive symptoms and cognitive status affect health-related quality of life in older patients with Parkinson's disease. J Am Geriatr Soc. 55 (2007) 1888-1890
73. Australian Institute of Health and Welfare. Residential aged care in Australia 2006-07: A statistical overview. http://www.aihw.gov.au/publications/index.cfm/title/10589 Accessed December 1, 2008
74. Ryan J., Carriere I., Ritchie K., et al. Late-life depression and mortality: Influence of gender and antidepressant use. Br J Psychiatry 192 (2008) 12-18